About this trial
The purpose of this study is to determine the efficacy and safety of levofloxacin combined with endovascular thrombectomy in treating acute ischemic stroke due to large vessel occlusion of anterior circulation.
Eligibility criteria
Qualifiers
Age 18-75 years.
Patients with clinically confirmed acute ischemic stroke within 24 hours after onset, CTA or DSA confirmed anterior circulation large vessel occlusion (ICA, M1/proximal M2 segment of MCA, tandem lesions), met the current guidelines for emergency endovascular interventional therapy, and underwent emergency thrombectomy.
mRS≤1 before stroke onset.
Signed and dated informed consent is obtained.
Disqualifiers
Patients with contraindications to emergency thrombectomy;
The head CT showed large facial cerebral infarction;
Patients using glucocorticoids, antiarrhythmic drugs (class I and class III antiarrhythmic drugs: quinidine, procaine amine, lidocaine, phenytoin sodium, verapamil, etc.), and quinolones within 14 days;
Patients with other diseases that may aggravate adverse drug reactions, such as ventricular arrhythmias, prolonged QT interval (male: QTc>430ms, female: QTc>450ms), severe cardiac insufficiency (NYHA functional grade ≥ III), myasthenia gravis, peripheral neuropathy, seizures, tendon-related diseases, severe immune system-related diseases, hematological diseases, active hepatitis or cirrhosis, serious respiratory diseases;
Trial design
Treatments tested in this trial
- Levofloxacin
- Levofloxacin simulant
Treatment groups
Locations
Sponsors and collaborators
Yi Yang
Lead sponsor
The First Hospital of Jilin University
Sponsor institution